STAT+: Pharmalittle: Amgen ends two lupus programs; Illumina sequencers have security vulnerability
In a survey of patient advocacy groups, 52% thought brand-name pharma companies did a “fair” to “poor” job of providing access to medicines.
News
STAT+: Parker Institute extends ‘crazy idea’ funding to two more cancer centers
“If you give some money without strings attached, that’s huge. That’s a big deal for an investigator.” […]
News
STAT+: Pharmalittle: ICER cuts cost-effective price for Pfizer Covid pill; McDonald’s sets targets to reduce antibiotic use in cattle
The Institute for Clinical and Economic Review cut its suggested price range for the Pfizer Covid-19 pill Paxlovid by more than 80%. […]
News
STAT+: Gilead defeats federal government in closely watched battle over patents for HIV prevention pills
A U.S. court jury handed a major win to Gilead Sciences on Tuesday in a closely watched battle with the federal government over the rights to groundbreaking HIV prevention pills. […]
